# D. Boral ARC Acquisition I Corp. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/D. Boral ARC Acquisition I Corp.). ## Overview D. Boral ARC Acquisition I Corp. is a special purpose acquisition company formed to complete a merger or similar business combination with an operating business. It raised capital through its IPO and private placement and is now focused on identifying and negotiating a target, with stated interest in sectors where its team has experience such as technology, healthcare, and logistics. ## Products & services • SPAC formation and capital raising • Target sourcing and acquisition execution • Merger, share exchange, or asset acquisition structuring • Due diligence and transaction negotiation • Public-market listing path for a target business - **SPAC capital formation** (0%) — IPO units, private placement units, and trust-account capital used to fund a future business combination. - **Target sourcing and deal origination** (0%) — Proprietary sourcing of acquisition candidates through sponsor and advisor networks. - **Transaction structuring and execution** (0%) — Negotiation, due diligence, and closing support for mergers and similar combinations. - **Public company platform** (0%) — A listed vehicle that can provide a target with access to public equity markets. - SPAC formation and IPO capital raising - Target sourcing and proprietary deal flow access - Merger, share exchange, or asset acquisition execution - Due diligence, negotiation, and transaction structuring - Public listing pathway for an acquired operating company ## Customers The company does not sell products to end customers today; its counterparties are investors in the IPO and sponsor financing, and its future customers are acquisition targets and their owners. Those targets are typically private companies seeking a public listing, growth capital, or a transaction partner with SPAC execution experience. The reports indicate a focus on businesses in technology, healthcare, and logistics, with an ability to evaluate cross-border opportunities. - **Public IPO investors** (primary) — Buy units and warrants in the SPAC structure, seeking optionality on a future business combination. - **Sponsor and private placement investors** (primary) — Provide capital through private placement units and support the acquisition process. - **Private operating company targets** (primary) — Potential merger partners that want public-market access, capital, and transaction expertise. - **Target company owners and management teams** (secondary) — Sell or combine their businesses through a SPAC transaction to accelerate growth and liquidity. - Public investors buying IPO units and redeemable warrants - Sponsor and private placement investors providing seed capital - Private company owners seeking a SPAC merger or sale - Growth businesses wanting access to public markets - Targets in technology, healthcare, logistics, and adjacent sectors ## Geography The company is incorporated in the British Virgin Islands and is managed from the United States, with its IPO conducted in the U.S. public markets. Management says it can pursue targets in any geography and has experience across North America, Europe, Asia, and emerging markets, which broadens the acquisition opportunity set and adds cross-border execution complexity. - Incorporated in the British Virgin Islands - Managed from the United States and listed via U.S. markets - Can pursue targets in any country or region - Management cites prior transactions across North America, Europe, Asia - Cross-border focus increases regulatory and currency complexity ## Strategy The company’s strategy is to identify a high-quality target that fits its team’s SPAC and investment banking experience, then execute a merger or similar combination using IPO proceeds and related financing. Management emphasizes proprietary deal flow, disciplined diligence, and sectors where it believes it has an edge, especially technology, healthcare, and logistics. The recent merger agreement with Exascale shows the company has moved from blank-check formation toward an announced transaction. - **Complete the initial business combination** (short-term) — The SPAC has no operating revenue until a transaction closes, so execution is the core value driver. - **Leverage proprietary deal flow** (short-term) — Exclusive sourcing can improve target quality and reduce auction competition. - **Target sectors aligned with team expertise** (medium-term) — Sector familiarity should improve diligence, valuation, and post-close execution. - **Execute cross-border transactions** (medium-term) — International reach expands the target universe and can uncover undervalued growth assets. - Source proprietary off-market targets through sponsor relationships - Focus on sectors where management has prior transaction expertise - Use disciplined diligence to improve deal quality and closing odds - Structure transactions with cash, stock, and debt as needed - Advance from SPAC formation to an announced business combination ## Risks The main risk is that the company may not complete a business combination within the required timeframe, which would force liquidation and redemption of public shares. It also faces execution risk around target valuation, due diligence, financing, and post-merger integration, while market conditions can affect both investor support and the attractiveness of targets. Because it is a SPAC, the business has no operating revenue and depends on interest income, trust-account mechanics, and transaction completion to create value. - **Failure to complete an initial business combination** [critical] — The company is a blank check vehicle and must close a deal within its deadline or liquidate. - **Going concern / liquidity pressure** [high] — The filing states substantial doubt about continuing as a going concern and ongoing costs continue until a deal closes. - **Deal execution and valuation risk** [high] — A poor target selection or overpayment can impair post-merger performance and investor returns. - **Cross-border regulatory and geopolitical risk** [medium] — Management highlights international transactions, which can face approval, currency, and political hurdles. - Failure to close a business combination could trigger liquidation - Target valuation or diligence errors could destroy shareholder value - Cross-border deals add regulatory, currency, and geopolitical risk - Public market conditions can reduce financing and redemption support - No operating revenue until a transaction closes ## Accounting Accounting is dominated by SPAC-specific items rather than operating revenue recognition. Investors should watch the trust account, redeemable ordinary shares, warrant accounting, and the treatment of formation and transaction costs, because these items drive reported income, equity classification, and liquidity presentation. The company also discloses interest income on the trust account and a going-concern assessment, both of which can materially affect near-term reported results. - **Redeemable ordinary shares** — Changes balance sheet presentation and book value per share - **Warrant accounting and dilution** — May be anti-dilutive until future events occur - **Trust account interest income** — Can create reported net income despite no operating business - **Formation and transaction costs** — Drives early-period losses and cash usage - **Going concern assessment** — Signals dependence on completing a transaction within the deadline - Redeemable Class A shares affect equity and redemption accounting - Warrants can be anti-dilutive and affect EPS presentation - Trust-account interest drives non-operating income - Formation and transaction costs create early-period losses - Going-concern disclosure reflects SPAC deadline and liquidity risk --- *Last updated: 2026-04-28T20:00:11.793938+00:00*